Small interference RNA targeting tissue factor inhibits human lung adenocarcinoma growth in vitro and in vivo

Journal of Experimental and Clinical Cancer Research

Volumn 30, Issue 1, 2011, Pages

  Xu, Chengcheng ^a   Gui, Qi ^a   Chen, Wenshu ^a   Wu, Leiming ^a   Sun, Wei ^a   Zhang, Ni ^a   Xu, Qinzi ^a   Wang, Jianing ^a   Fu, Xiangning ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

A549; Gene therapy; Lung adenocarcinoma; RNA interference; Tissue factor

Indexed keywords

GELATINASE A; GELATINASE B; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; SMALL INTERFERING RNA; THROMBOPLASTIN; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GENE THERAPY; CANCER INHIBITION; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG ADENOCARCINOMA; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; ADENOCARCINOMA; ANIMAL; BAGG ALBINO MOUSE; CELL MOTION; DRUG SCREENING; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; LUNG TUMOR; METABOLISM; NUDE MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR VOLUME;

ADENOCARCINOMA; ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; THROMBOPLASTIN; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79957457514     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-30-63     Document Type: Article

References (37)

1. Cancer statistics, 2010. A Jemal R Siegel J Xu E Ward, CA Cancer J Clin 2010 60 277 300 10.3322/caac.20073 20610543
2. Global cancer statistics, 2002. DM Parkin F Bray J Ferlay P Pisani, CA Cancer J Clin 2005 55 74 108 10.3322/canjclin.55.2.74 15761078 (Pubitemid 40372904)
3. Time trends of surgical outcome in patients with non-small cell lung cancer. T Hanagiri T Baba T So M Yasuda M Sugaya K Ono H Uramoto M Takenoyama K Yasumoto, J Thorac Oncol 2010 5 825 829 10.1097/JTO.0b013e3181d5e47f 20421823
4. The structural biology of expression and function of tissue factor. TS Edgington N Mackman K Brand W Ruf, Thromb Haemost 1991 66 67 79 1833852
5. Tissue factor-factor VIIa signaling. LV Rao UR Pendurthi, Arterioscler Thromb Vasc Biol 2005 25 47 56 15569823 (Pubitemid 40054253)
6. Tissue factor expression in non-small cell lung cancer: Relationship with vascular endothelial growth factor expression, microvascular density, and K-ras mutation. S Regina J Rollin C Blechet S Iochmann P Reverdiau Y Gruel, Journal of Thoracic Oncology 2008 3 689 697 10.1097/JTO.0b013e31817c1b21 18594312
7. Immunohistochemical identification of tissue factor in solid tumors. NS Callander N Varki LV Rao, Cancer 1992 70 1194 1201 10.1002/1097-0142(19920901) 70:5<1194::AID-CNCR2820700528 3.0.CO;2-E 1381270
8. Predictive value of tissue factor bearing microparticles in cancer associated thrombosis. JI Zwicker, Thromb Res 2010 125 Suppl 2 89 91 20434015
9. Microparticles, thrombosis and cancer. A Aharon B Brenner, Best Pract Res Clin Haematol 2009 22 61 69 10.1016/j.beha.2008.11.002 19285273
10. Activation of blood coagulation in cancer: Trousseau's syndrome revisited. FR Rickles RL Edwards, Blood 1983 62 14 31 6407544 (Pubitemid 13070586)
11. Ex vivo and in vivo delivery of anti-tissue factor short interfering RNA inhibits mouse pulmonary metastasis of B16 melanoma cells. M Amarzguioui Q Peng MT Wiiger V Vasovic E Babaie T Holen JM Nesland H Prydz, Clin Cancer Res 2006 12 4055 4061 10.1158/1078-0432.CCR-05-2482 16818705 (Pubitemid 44078093)
12. Downregulation of tissue factor by RNA interference in human melanoma LOX-L cells reduces pulmonary metastasis in nude mice. X Wang M Wang M Amarzguioui F Liu O Fodstad H Prydz, Int J Cancer 2004 112 994 1002 10.1002/ijc.20527 15386437 (Pubitemid 39507005)
13. Strategies for silencing human disease using RNA interference. DH Kim JJ Rossi, Nat Rev Genet 2007 8 173 184 10.1038/nrg2006 17304245
14. In vivo application of RNA interference: from functional genomics to therapeutics. PY Lu F Xie MC Woodle, Adv Genet 2005 54 117 142 16096010
15. Positional effects of short interfering RNAs targeting the human coagulation trigger Tissue Factor. T Holen M Amarzguioui MT Wiiger E Babaie H Prydz, Nucleic Acids Res 2002 30 1757 1766 10.1093/nar/30.8.1757 11937629 (Pubitemid 34679753)
16. The Bradford method for protein quantitation. NJ Kruger, Methods Mol Biol 1994 32 9 15 7951753
17. Small interference RNA targeting Kruppel-like factor 8 inhibits the renal carcinoma 786-0 cells growth in vitro and in vivo. WJ Fu JC Li XY Wu ZB Yang ZN Mo JW Huang GW Xia Q Ding KD Liu HG Zhu, J Cancer Res Clin Oncol 2010 136 1255 1265 10.1007/s00432-010-0776-0 20182889
18. Effect of small interfering RNA targeting survivin gene on biological behaviour of bladder cancer. JQ Hou J He XL Wang DG Wen ZX Chen, Chin Med J (Engl) 2006 119 1734 1739 (Pubitemid 44710288)
19. Successful incorporation of short-interfering RNA into islet cells by in situ perfusion. SP Bradley TF Kowalik C Rastellini MA DaCosta AB Bloomenthal L Cicalese GP Basadonna ME Uknis, Transplant P 2005 37 233 236 10.1016/j.transproceed.2004.12.181 (Pubitemid 40459747)
20. Effect of tissue factor deficiency on mouse and tumor development. JR Toomey KE Kratzer NM Lasky GJ Broze Jr, Proc Natl Acad Sci USA 1997 94 6922 6926 10.1073/pnas.94.13.6922 9192667 (Pubitemid 27281966)
21. Inhibition of tissue factor signaling suppresses tumor growth. HH Versteeg F Schaffner M Kerver HH Petersen J Ahamed B Felding-Habermann Y Takada BM Mueller W Ruf, Blood 2008 111 190 199 10.1182/blood-2007-07-101048 17901245
22. The role of the hemostatic system in tumor growth, metastasis, and angiogenesis: Tissue factor is a bifunctional molecule capable of inducing both fibrin deposition and angiogenesis in cancer. FR Rickles M Shoji K Abe, Int J Hematol 2001 73 145 150 10.1007/BF02981930 11372724 (Pubitemid 33758853)
23. Dissemination and growth of cancer cells in metastatic sites. AF Chambers AC Groom IC MacDonald, Nature Reviews Cancer 2002 2 563 572 10.1038/nrc865 12154349 (Pubitemid 37328923)
24. The changing epidemiology of lung cancer in Europe. ML Janssen-Heijnen JW Coebergh, Lung Cancer 2003 41 245 258 10.1016/S0169-5002(03)00230-7 12928116 (Pubitemid 36970181)
25. International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising. SS Devesa F Bray AP Vizcaino DM Parkin, Int J Cancer 2005 117 294 299 10.1002/ijc.21183 15900604 (Pubitemid 41379403)
26. Cancer invasion and metastasis: changing views. MJ Duffy PM McGowan WM Gallagher, J Pathol 2008 214 283 293 10.1002/path.2282 18095256 (Pubitemid 351212383)
27. Matrix metalloproteinases and tumor metastasis. EI Deryugina JP Quigley, Cancer Metastasis Rev 2006 25 9 34 10.1007/s10555-006-7886-9 16680569 (Pubitemid 43723979)
28. Tumor angiogenesis and tissue factor. J Folkman, Nat Med 1996 2 167 168 10.1038/nm0296-167 8574960 (Pubitemid 26054981)
29. Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism. TA Hembrough GM Swartz A Papathanassiu GP Vlasuk WE Rote SJ Green VS Pribluda, Cancer Res 2003 63 2997 3000 12782609 (Pubitemid 36667175)
30. Tissue-factor expression in human non-small-cell lung carcinoma measured by immunohistochemistry: correlation between tissue factor and angiogenesis. R Koomagi M Volm, Int J Cancer 1998 79 19 22 10.1002/(SICI)1097-0215(19980220)79: 1<19::AID-IJC4 3.0.CO;2-Z 9495352 (Pubitemid 28157720)
31. Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis. JL Yu L May V Lhotak S Shahrzad S Shirasawa JI Weitz BL Coomber N Mackman JW Rak, Blood 2005 105 1734 1741 10.1182/blood-2004-05-2042 15494427 (Pubitemid 40223697)
32. Tissue factor and cancer metastasis: the role of intracellular and extracellular signaling pathways. HH Versteeg CA Spek MP Peppelenbosch DJ Richel, Mol Med 2004 10 6 11 10.1007/s00894-003-0157-6 15502877 (Pubitemid 39440315)
33. Differential expression of protease-activated receptors-1 and -2 in stromal fibroblasts of normal, benign, and malignant human tissues. MR D'Andrea CK Derian RJ Santulli P Andrade-Gordon, Am J Pathol 2001 158 2031 2041 10.1016/S0002-9440(10)64675-5 11395381 (Pubitemid 32545189)
34. G-protein-coupled receptors and cancer. RT Dorsam JS Gutkind, Nat Rev Cancer 2007 7 79 94 10.1038/nrc2069 17251915 (Pubitemid 46164746)
35. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. C Widmann S Gibson MB Jarpe GL Johnson, Physiol Rev 1999 79 143 180 9922370 (Pubitemid 29056951)
36. Regulation of neuronal survival by the serine-threonine protein kinase AKT. H Dudek SR Datta TF Franke MJ Birnbaum R Yao GM Cooper RA Segal DR Kaplan ME Greenberg, Science 1997 275 661 665 10.1126/science.275.5300.661 9005851 (Pubitemid 27061332)
37. Targeting tissue factor-expressing tumor angiogenesis and tumors with EF24 conjugated to factor VIIa. M Shoji A Sun W Kisiel YJ Lu H Shim BE McCarey C Nichols ET Parker J Pohl CA Mosley AR Alizadeh DC Liotta JP Snyder, J Drug Target 2008 16 185 197 10.1080/10611860801890093 18365880 (Pubitemid 351460647)